Probabilistic aggregate and cumulative toxicological risk assessment of bisphenol analogues (BPA, BPS, BPF, BPAF) from personal care products in the Korean population
Food and Chemical Toxicology · 2026-06 · 212 · 116064
DOI: 10.1016/j.fct.2026.116064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2026-06. Verfasst von YiSi Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Bioscience and Biotechnology, Institute of Bioscience and Biotechnology, College of Life Science, Sejong University, Seoul,…. Hauptthemen laut MEDLINE: Phenols, Benzhydryl Compounds, Sulfones. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Ministry of Education, Ethiopia, National Research Foundation of Korea, Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Bisphenol analogues such as BPA, BPS, BPF, and BPAF are widely used in consumer products, raising concern over their combined health risks. This study conducted a probabilistic population-level assessment of cumulative estrogenic exposure to these compounds from personal care products among Korean adults. Using data from a nationwide survey (n = 3,000), product concentration records, and 100,000-iteration Monte Carlo simulations stratified by sex, daily external doses were estimated. Cumulative estrogenic exposure was expressed as BPA equivalents based on relative potency factors, and risks were evaluated through margin of exposure (MOE) and hazard quotient (HQ) analyses. BPF dominated mass-based exposure (∼82%), while BPAF contributed most after potency adjustment. The median cumulative exposure was 4.1 × 10-3 μg/kg bw/day, with MOEs above 104 and HQs well below 1. Scenario-based uncertainty evaluation (clearance, absorption, and toothpaste ingestion retention) indicated that conclusions remained robust under plausible parameter ranges. Overall, current exposure levels suggest minimal estrogenic risk, yet high-potency analogues such as BPAF warrant continued monitoring. The RPF-MOE framework provides a practical tool for evaluating and managing bisphenol substitutes in consumer products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrative Bioscience and Biotechnology, Institute of Bioscience and Biotechnology, College of Life Science, Sejong University, Seoul, 05006, Republic of Korea.
- Department of Safety Assessment, Safety CoreLab Co., Ltd., Seoul, 04309, Republic of Korea.
- Safety Assessment Solution Co., Ltd., Seoul, 04309, Republic of Korea.
- Department of Food and Nutrition, Gachon University, Seongnam-si, 13120, Republic of Korea.
- Department of Integrative Bioscience and Biotechnology, Institute of Bioscience and Biotechnology, College of Life Science, Sejong University, Seoul, 05006, Republic of Korea. Electronic address: yjlee@sejong.ac.kr.
Förderung
- Ministry of Education, Ethiopia
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
- Ministry of Environment
Zitieren
APA
Yang, Y., Choi, K., Shin, H. J., Hwang, M., & Lee, Y. (2026). Probabilistic aggregate and cumulative toxicological risk assessment of bisphenol analogues (BPA, BPS, BPF, BPAF) from personal care products in the Korean population. Food and Chemical Toxicology, 212, 116064. https://doi.org/10.1016/j.fct.2026.116064
Vancouver
Yang Y, Choi K, Shin HJ, Hwang M, Lee Y. Probabilistic aggregate and cumulative toxicological risk assessment of bisphenol analogues (BPA, BPS, BPF, BPAF) from personal care products in the Korean population. Food and Chemical Toxicology. 2026;212:116064. doi:10.1016/j.fct.2026.116064
BibTeX
@article{Yang2026,
author = {Yang, YiSi and Choi, KeunOh and Shin, Hee June and Hwang, Myungsil and Lee, YoungJoo},
title = {Probabilistic aggregate and cumulative toxicological risk assessment of bisphenol analogues (BPA, BPS, BPF, BPAF) from personal care products in the Korean population},
journal = {Food and Chemical Toxicology},
year = {2026},
volume = {212},
pages = {116064},
doi = {10.1016/j.fct.2026.116064}
}
EUVIMED